Prevalence and genotype distribution of human papillomavirus in cytology specimens containing atypical glandular cells: A case-control study

Journal of Clinical Virology

Volumn 58, Issue 2, 2013, Pages 432-436

  Namugenyi, S B ^a   Balsan, M J ^b   Glick, S N ^a   Jordan, J A ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Atypical glandular cell grade cytology; Case control study; HPV; HPV 16 18; HPV genotypes

Indexed keywords

VIRUS DNA;

ADULT; AGE; ARTICLE; CANCER CELL; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CYTOLOGY; DNA EXTRACTION; FEMALE; GENOTYPE; GLANDULAR CELL CANCER; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NONHUMAN; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; UTERINE CERVIX CANCER; WART VIRUS;

ATYPICAL GLANDULAR CELL-GRADE CYTOLOGY; CASE-CONTROL STUDY; HPV; HPV 16/18; HPV GENOTYPES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; YOUNG ADULT;

EID: 84884534940     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.08.006     Document Type: Article

References (28)

1. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2:342-350.
2. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human papillomavirus and related cancers in world. Summary Report 2010. [accessed: 28.11.12]. http://www.who.int/hpvcentre.
3. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29.
4. Lai C.R., Hsu C.Y., Li A.F. The role of the Pap smear diagnosis: atypical glandular cells (AGC), intraepithelial neoplasia 2012, 365-380. InTech, Available from: http://www.intechopen.com/books/intraepithelial-neoplasia/the-role-of-the-pap-smeardiagnosis-atypical-glandular-cells-agc. S. Srivastava (Ed.).
5. Smith H.O., Tiffany M.F., Qualls C.R., Key C.R. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States - a 24-year population-based study. Gynecol Oncol 2000, 78:97-105.
6. Wingo P.A., Cardinez C.J., Landis S.H., Greenlee R.T., Ries L.A., et al. Long-term trends in cancer mortality in the United States, 1930-1998. Cancer 2003, 97(12 Suppl.):3133-3275.
7. Behtash N., Nazari Z., Fakhrejahani F., Khafaf A., Azar E.G. Clinical and histological significance of atypical glandular cell on Pap smear. Aust N Z J Obstet Gynaecol 2007, 4:46-49.
8. Lee K.R., Darragh T.M., Joste N.E., Krane J.F., Sherman M.E., et al. Atypical glandular cells of undetermined significance (AGUS): interobserver reproducibility in cervical smears and corresponding thin-layer preparations. Am J Clin Pathol 2002, 117:96-102.
9. Chen S.F., Yang S.F., Chu T.Y., Lai H.C., Lin Y.W., et al. Which test is a better strategy to determine the outcome of atypical glandular cell-categorized Pap smears? Immunocytochemical p16NK4a expression or human papillomavirus test-a retrospective cohort study. Gynecol Oncol 2005, 99:578-584.
10. Apgar B.S., Kittendorf A.L., Bettcher C.M., Wong J., Kaufman A.J. Update on ASCCP consensus guidelines for abnormal cervical screening tests and cervical histology. Am Fam Physician 2009, 80:147-155.
11. Wright T.C, Massad L.S., Dunton C.J., Spitzer M., Wilkinson E.J., et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. Am J Obstet Gynecol 2007, 197:346-355.
12. Ronnett B.M., Manos M.M., Ransley J.E., Fetterman B.J., Kinney W.K., et al. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 1999, 30:816-825.
13. Krane J.F., Lee K.R., Sun D., Yuan L., Crum C.P. Atypical glandular cells of undetermined significance: outcome predictions based on human papillomavirus testing. Am J Clin Pathol 2004, 121:87-92.
14. Derchain S.F., Rabelo-Santos S.H., Sarian L.O., Zeferino L.C., de Oliveira Zambeli E.R., et al. Human papillomavirus DNA detection and histological findings in women referred for atypical glandular cells or adenocarcinoma in situ in their Pap smears. Gynecol Oncol 2004, 95:618-623.
15. Irvin W., Evans S.R., Andersen W., Jazaeri A., Taylor P., et al. The utility of HPV triage in the management of cytological AGC. Am J Obstet Gynecol 2005, 193:559-567.
16. de Oliveira E.R., Derchain S.F., Sarian L.O., Rabelo-Santos S.H., Gontijo R.C., et al. Prediction of high-grade cervical disease with human papillomavirus detection in women with glandular and squamous cytologic abnormalities. Int J Gynecol Cancer 2006, 16:1055-1062.
17. Saqi A., Gupta P.K., Erroll M., Babiac A., Blackmun D., et al. High-risk human papillomavirus testing: a marker for atypical glandular cells. Diagn Cytopathol 2006, 34:235-239.
18. Diaz-Montes T.P., Farinola M.A., Zahurak M.L., Bristow R.E., Rosenthal D.L. Clinical utility of atypical glandular cells (AGC) classification: cytological comparison and relationship to HPV results. Gynecol Oncol 2007, 104:366-371.
19. Liao S., Rodgers W.H., Kauderer J., Bonfiglio T.A., Walker J.L., et al. Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group in United States. Int J Cancer 2009, 125:2434-2440.
20. Rabelo-Santos S.H., Derchain S.F., Villa L.L., Costa M.C., Sarian L.O., et al. Human papillomavirus-specific genotypes in cervical lesions of women referred for smears with atypical glandular cells or adenocarcinoma in situ. Int J Gynecol Pathol 2009, 28:272-278.
21. INK4a Is superior to high-risk human papillomavirus testing in cervical cytology for the prediction of underlying high-grade dysplasia. Cancer Cytopathol 2010, 118:146-156.
22. Liao S.Y., Rodgers W.H., Kauderer J., Bonfiglio T.A., Darcy K.M., et al. Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) Study. Br J Cancer 2011, 104:353-360.
23. Zeferino L.C., Rabelo-Santos S.H., Villa L.L., Sarian L.O., Costa M.C., et al. Value of HPV-DNA test in women with cytological diagnosis of atypical glandular cells (AGC). Eur J Obstet Gynecol Reprod Biol 2011, 159:160-164.
24. Carter L.R., Kang L., Darcy K.M., Kauderer J., Liao S., et al. A modified Latent Class Model assessment of human papillomavirus-based screening test for cervical lesions in women with atypical glandular cells: a Gynecolgic Oncology Group study. Cancer Causes Control 2012, 23:2013-2021.
25. Mulhem E., Amin M., Copeland J., Sharma J., Hunter S. Type-specific human papillomavirus DNA detected in atypical glandular cell pap tests. Acta Cytologica 2012, 56:155-159.
26. Walboomers J.M.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999, 189:12-19.
27. Jit M., Gay N., Soldan K., Hong Choi Y., Edmunds W.J. Estimating progression rates for human papillomavirus infection from epidemiological data. Med Decis Making 2010, 30:84-98.
28. Sharpless K.E., O'Sullivan D.M., Schnatz P.F. The utility of human papillomavirus testing in the management of atypical glandular cells on cytology. J Low Genit Tract Dis 2009, 13:72-78.